MegaQuinone
MegaQuinone, licence 80112620: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- MegaQuinone K2-7
- Licence holder
- Novozymes North America Inc.
- NPN or DIN-HM
- 80112620
- Status
- Active licence
- Licence date
- 3 September 2021
- Revision date
- 17 June 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Glycinate de magnésium | 36.0 mg | 36,000 µg |
| Vitamine K2 Source : Ménaquinone 7 | 74.0 mcg | 74 µg |
| Vitamine K1 Source : Vitamine K1 | 46.0 mcg | 46 µg |
Non-medicinal ingredients
Cellulose, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 ans | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in connective tissue formation. Helps in energy metabolism and tissue formation. Helps in energy metabolism, tissue formation and bone development. Helps in the development and maintenance of bones and teeth and maintain proper muscle function and tissue formation. Helps in the maintenance of bones. Helps maintain healthy skin and connective tissue formation. Helps to maintain (proper) muscle function. Helps to maintain healthy bones, hair, nail and/or skin. Helps to maintain heart muscle function. Helps to maintain normal electrolyte balance. Helps with immune function. Provides/Source of/An electrolyte (for the maintenance of good health).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80112620
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.